In T2DM patients, increased mRNA and protein expression of SGLT1, GLUT2, and GLUT5 promote the intestine uptake of glucose, galactose and fructose, respectively [41]. This evidence concerns the gene SLC2A2 and type 2 diabetes mellitus.